Oncology Expansion

[anonymous]

Is this still a great division at Pfizer with all the changes?

 

[anonymous]

Well, my guess another restructure will occur when they can lay off the seagen folks as for now everyone needs to stay on board the ship. just wait til the seagen contract runs out and numbers arenot met we will be back to larger geographies.

downsizing is inevitable its just when it will happen. Certain markets have more people than they can place.

 

[anonymous]

I’m not excited about trying to move over to Oncology. A few reasons are 1) lots of off label use by oncologists and I know Pfizer wouldn’t support me for those conversations. 2) lots of clinical trials scoop up available patients 3) astronomical prices are good targets for politicians and other pundits who target pharma

 

[anonymous]

I’m not excited about trying to move over to Oncology. A few reasons are 1) lots of off label use by oncologists and I know Pfizer wouldn’t support me for those conversations. 2) lots of clinical trials scoop up available patients 3) astronomical prices are good targets for politicians and other pundits who target pharma

JOBS POSTED DAILY, and Not Seagen folks either!

 

[anonymous]

I’m not excited about trying to move over to Oncology. A few reasons are 1) lots of off label use by oncologists and I know Pfizer wouldn’t support me for those conversations. 2) lots of clinical trials scoop up available patients 3) astronomical prices are good targets for politicians and other pundits who target pharma

Conversations with Oncologists? Ha - no one ever gets access.

 

[anonymous]

I’m not excited about trying to move over to Oncology. A few reasons are 1) lots of off label use by oncologists and I know Pfizer wouldn’t support me for those conversations. 2) lots of clinical trials scoop up available patients 3) astronomical prices are good targets for politicians and other pundits who target pharma

Really…. I think you’re just scared of the challenge.

 

[anonymous]

I've been in primary care divisions, psych div, hospital div and finally Oncology.
Oncology was the best by far. Once they turn Oncology it into primary care-like via call metrics and signatures, it will suck too.

 

[anonymous]

I’m not excited about trying to move over to Oncology. A few reasons are 1) lots of off label use by oncologists and I know Pfizer wouldn’t support me for those conversations. 2) lots of clinical trials scoop up available patients 3) astronomical prices are good targets for politicians and other pundits who target pharma

My goodness, where does one even begin? Assuming you’re a rep and not in medical, let’s give it a shot. 1) You won’t be discussing ANYTHING off label EVER. You would NEVER need to be supported. That you think docs are out there doing whatever they want regardless of the PI and guidelines shows how uninformed you are. 2) Clinical trial participation is < 8%. Many non-academic centers, where the overwhelming number of patients are treated, are fortunate to enroll a few patients in a trial. 3) High prices aren’t unique to oncology. If you’re so bothered by it then why are you here?

 

[anonymous]

I've been in primary care divisions, psych div, hospital div and finally Oncology.
Oncology was the best by far. Once they turn Oncology it into primary care-like via call metrics and signatures, it will suck too.

Once they…

Already happening.

 

[anonymous]

I’m not excited about trying to move over to Oncology. A few reasons are 1) lots of off label use by oncologists and I know Pfizer wouldn’t support me for those conversations. 2) lots of clinical trials scoop up available patients 3) astronomical prices are good targets for politicians and other pundits who target pharma

Moron

 

[anonymous]

My goodness, where does one even begin? Assuming you’re a rep and not in medical, let’s give it a shot. 1) You won’t be discussing ANYTHING off label EVER. You would NEVER need to be supported. That you think docs are out there doing whatever they want regardless of the PI and guidelines shows how uninformed you are. 2) Clinical trial participation is < 8%. Many non-academic centers, where the overwhelming number of patients are treated, are fortunate to enroll a few patients in a trial. 3) High prices aren’t unique to oncology. If you’re so bothered by it then why are you here?

Hilarious. Oncology reps who think they are anything more than a pharma rep. Go fetch me a donut

 

[anonymous]

Hilarious. Oncology reps who think they are anything more than a pharma rep. Go fetch me a donut

Those of us in oncology have salaries and perks that say we are.

 

[anonymous]

Those of us in oncology have salaries and perks that say we are.

Pfizer not backfilling Eliquis sales reps: THEY ARE ALL IN ONCOLOGY and RARE DISEASE NOW> Metrics/ONLY TARGET CALLS and ALL THE OTHER BS THAT COMES WITH PRIMARY CARE! TIME TO SAY GOODBYE TO THIS DUMPSTER FIRE OF A COMPANY. ARROGANT MGMENT AND ALL PC MANAGEMENT. BEND OVER!​

 

[anonymous]

Those of us in oncology have salaries and perks that say we are.

Are pharma reps? Yep, that you are. I’ll take a cruller please

 

[anonymous]

worse oncology sales division! more like primary care-ride alongs 3 times a quarter with limited access and pre call planning and agenda before ride alongs.

 

[anonymous]

worse oncology sales division! more like primary care-ride alongs 3 times a quarter with limited access and pre call planning and agenda before ride alongs.

 

[anonymous]

Phuck Pfizer. Crimes against humanity

 

[anonymous]

Phuck Pfizer. Crimes against humanity

pfizerforall... They want you. Little stupid hat wearers. For example, gottlieb is a little stupid hat wearer.

 

[anonymous]

Those of us in oncology have salaries and perks that say we are.

lol. You do less than a KAM. Drive 1k+ a week to hand out clinicals nobody reads. Congrats on your big salary but you’re not fooling anyone….